Research Article

Antioxidants: Their Role in Health and Disease

Sheikh Arshad Saeed, Mian Zainul Sajadeen Urfy, Talaha Mubarak Ali, , Farhad Wazirali Khimani and Anwar-ul-Hassan Gilani
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

During the past few years there has been an escalation of interest in the role of antioxidants in health and disease. Antioxidants act as free radical scavengers and can thus play significant protective role in many age-related and chronic inflammatory diseases. This article reviews the role of antioxidants vitamin C, E and β-carotene in the process of ageing and diseases like coronary heart disease, Alzheimer`s disease and cancer. The phenomenon of ageing has been mystery for mankind since long. Naturally occurring antioxidants can help slow this process by preventing us from harmful effects of ageing. The diet of healthy centenarians also shows high intake of antioxidants like vitamin A, C and E. On the other hand lipid peroxidation is necessary for atheroma formation in coronary arteries leading to heart attacks. This process begins early in childhood. By taking antioxidants this process can be significantly slowed down or even terminated. Reactive oxygen species may also lead to DNA changes and gene mutations, a primary pathology behind uncontrolled cell proliferation and tumorigenesis. Vitamin A and E reduce this stress and have been shown to decrease the risk of prostate and gastric cancers. Dementia and Alzheimer`s affects a large proportion of elderly population. These are a result of oxidative damage going on in our brain from our early life. Antioxidants also contribute in preventing these neurodegenerative processes and may improve the standard of living of the elderly.

Related Articles in ASCI
Search in Google Scholar
View Citation
Report Citation

  How to cite this article:

Sheikh Arshad Saeed, Mian Zainul Sajadeen Urfy, Talaha Mubarak Ali, , Farhad Wazirali Khimani and Anwar-ul-Hassan Gilani, 2005. Antioxidants: Their Role in Health and Disease. International Journal of Pharmacology, 1: 226-233.

DOI: 10.3923/ijp.2005.226.233



  1. Maxwell, S.R., 1999. Antioxidants vitamin supplements: Update of their potential benefits and possible risks. Drug Safety, 21: 253-256.

  2. Simopoulos, A.P., 2004. The traditional diet of Greece and cancer. Eur. J. Cancer Prev., 13: 219-230.

  3. Irshad, M. and P.S. Chaudhuri, 2002. Oxidant-antioxidant system: Role and significance in human body. Indian J. Exp. Biol., 40: 1233-1239.
    PubMed  |  

  4. Harman, D., 1984. Free radical theory of ageing: The free radical diseases. Age, 7: 111-131.

  5. Haliwell, B. and J.M.C. Gutteridge, 1989. Free Radicals in Biology and Medicine. 2nd Edn., Clarendon Press, Oxford

  6. Harman, D., 1998. Ageing: Phenomena and Theories. Ann. N. Y. Acad. Sci., 854: 1-7.

  7. Harman, D., 1982. Nutritional implications of the free radical theory of ageing. J. Am. College Nutr., 1: 27-34.
    Direct Link  |  

  8. Harman, D., 1993. Free radical involvement in ageing: Pathophysiology and therapeutic implications. Drugs Ageing, 3: 60-80.

  9. Wickens, A.P., 2001. Ageing and free radical theory. Respirat. Physiol., 128: 379-391.
    Direct Link  |  

  10. Kasapoglu, M. and T. Ozeben, 2001. Alteratons of antioxidant enzymes and oxidative stress markers in ageing. Exp. Gerontol., 36: 209-220.
    CrossRef  |  

  11. Mecocci, P., M.C. Polidori, L. Troiano, A. Cherubini and R. Cecchetti et al., 2000. Plasma antioxidants and longevity: A study on healthy centenarians. Free Radical Biol. Med., 28: 1243-1248.
    PubMed  |  

  12. Congy F., D. Bonnefont-Rousselot, S. Dever, J. Delattre and J. Emerit, 1995. Study of oxidative stress in elderly. Presse Med., 24: 1115-1118.

  13. Ruston, A., J. Clayton and M. Calnan, 1998. Patient's action during their cardiac event: Qualitative study exploring differences and modifiable factors. Br. Med. J., 316: 1061-1064.

  14. Kannel, W.B., D.L. McGee and A. Schatzkin, 1984. An epidemiological perspective of sudden death 26 year followup in the Framingham study. Drugs, 28: 1-16.

  15. Kendall, M.J., K.P. Lynch, A. Hjalmarson and J. Kjekshus, 1995. β-blockers and sudden cardiac death. Ann. Internal Med., 123: 358-367.
    Direct Link  |  

  16. Odeh, R.M. and L.A. Cornish, 1995. Natural antioxidants for prevention of atherosclerosis. Pharmacotherapy, 15: 648-659.

  17. Skyrme-Jones, R.A., R.C. O` Brien, K.L. Berry and I.T. Meredith, 2000. Vitamin E supplementation improves endothelial function in type I diabetes mellitus: A randomized placebo-controlled study. J. Am. College Cardiol., 36: 94-102.
    Direct Link  |  

  18. Stampfer, M.J., C.H. Hennekens, J.E. Mason, G.A. Colditz, B. Rosner and W.C. Willett, 1993. Vitamin E consumption and the risk of coronary heart disease in women. N. Engl. J. Med., 328: 1444-1449.
    Direct Link  |  

  19. Rimm, E.B., M.J. Stampfer, A. Ascherio, E. Giovannucci, G.A. Colditz and W.C. Willett, 1993. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med., 328: 1450-1456.
    PubMed  |  

  20. Stephens, N.G., A. Parsons, P.M. Schofield, F. Kelly K. Cheeseman and M.J. Mitchinson, 1996. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS). Lancet, 347: 781-786.

  21. Heitzer, T., S. Yla-Herttuala, E. Wild, J. Luoma and H. Drexler, 1999. Effect of vitamin E on endothelial vadodilator function in patients with hypercholesterolemia, chronic smoking or both. J. Am. College Cardiol., 33: 499-505.

  22. Bakaltcheva, I., D. Gyimah and T. Reid, 2001. Effects of α-tocopherol on platelets and the coagulation system. Platelets, 12: 389-394.
    Direct Link  |  

  23. Fairburn, K., 1992. α-Tocopherol, lipids and lipoproteins in the knee-joint synovial fluid and serum from patients with inflammatory joint disease. Clin. Sci., 83: 657-664.

  24. Heliovaara, M., P. Knekt, K. Aho, R.K. Aaran, G. Alfthan and A. Aromaa, 1994. Serum antioxidants and risk of rheumatoid arthritis. Ann. Rheumatic Dis., 53: 51-53.
    CrossRef  |  Direct Link  |  

  25. Blake, D.R., 1981. The importance of iron in rheumatoid disease. Lancet, 2: 1142-1144.

  26. Slater, T.F. and G. Block, 1991. Antioxidant vitamins and β-carotene in disease prevention. Am. J. Clin. Nutr., 53: 189S-396S.

  27. Jemal, A., A. Thomas, T. Murray and M. Thun, 2002. Cancer statistics. CA Cancer J. Clin., 52: 23-47.
    PubMed  |  

  28. Howe, H.L., P.A. Wingo and M.J. Thun, 2001. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J. Natl. Cancer Inst., 93: 824-842.
    PubMed  |  

  29. Doll, R. and R. Peto, 1981. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J. Natl. Cancer Inst., 66: 1191-1308.
    PubMed  |  

  30. WCRF. and AICR., 1997. Food Research and the Prevention of Cancer: A Global Perspective. 1st Edn., American Institute for Cancer Research, Washington, DC

  31. Henson, D.E., G. Block and M. Levine, 1993. Ascorbic acid: Biologic functions and relation to cancer. J. Natl. Cancer Inst., 185: 1483-1492.

  32. Carr, A. and B. Frei, 1999. Does vitamin C act as a pro-oxidant under physiological conditions? FASEB J., 13: 1007-1024.
    Direct Link  |  

  33. Drake, I.M., M.J. Davies and N.P. Mapstone, 1996. Ascorbic acid may protect against human gastric cancer by scavenging mucosal oxygen radicals. Carcinogenesis, 17: 559-562.

  34. Bowie, A.G. and L.A.J. O'Neill, 2000. Vitamin C inhibits NF-κ β activation by TNF via the activation of p38 mitogen-activated protein kinase. J. Immunol., 165: 7180-7188.

  35. Lutsenko, E.A., J.M. Carcamo and D.W. Golde, 2002. Vitamin C prevents DNA damage a biomarker? Free Radiclal Biol. Med., 277: 16895-16899.

  36. Albanes, D., O.P. Heinonen, J.K. Huttunen, P.R. Taylor and J. Virtamo et al., 1995. Effects of α-tocopherol and β-carotene supplements on cancer incidence in the α-tocopherol β-carotene cancer prevention study. Am. J. Clin. Nutr., 62: 1427S-1430S.
    Direct Link  |  

  37. Heinonen, O.P., L. Koss, D. Albanes, P.R. Taylor, A.M. Hartman et al., 1998. Prostate cancer and supplementation with α-tocopherol and β-carotene: Incidence and mortality in a controlled trial. J. Natl. Cancer Inst., 90: 440-446.
    CrossRef  |  Direct Link  |  

  38. Blot, W.J., J.Y. Li, P.R. Taylor, W. Guo and S. Dawsey et al., 1993. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence and disease-specific mortality in the general population. J. Natl. Cancer Inst., 185: 1483-1492.
    PubMed  |  

  39. Schwartz, J.L., 1996. The dual roles of nutrients as antioxidants and pro-oxidants: their effects on tumor cell growth. J. Nutr., 126: 1221S-1227S.

  40. Pfeifer, L.A., L.R. White, G.W. Ross, H. Petrovitch and L.J. Launer, 2002. Cerebral amyliod angiopathy and cognitive function: The HAAS autopsy study. Neurology, 58: 1629-1634.
    PubMed  |  

  41. Souder, E., J.R. Chastain and R.D. Williams, 2002. Dementaia in the new mellenium. Medsurg Nurs., 11: 61-70.
    PubMed  |  

  42. Markesbery, W.R., 2001. Oxidative stress hypothesis in Alzheimer's disease. Free Radical Biol. Med., 31: 315-320.

  43. Behl, C., 1997. Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res., 290: 471-480.

  44. Zandi, P.P., J.C. Anthony, A.S. Khachaturian, S.V. Stone and D. Gustafson et al., 2004. Reduced risk of Alzheimer`s disease risk in users of antioxidant vitamin supplements: Cache county study group. Arch Nerol., 61: 82-88.
    PubMed  |  

  45. Charlton, K.E., T.L. Rabinowitz, L.B. Geffen and M.A. Dhansay, 2004. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients. J. Nutr. Health Ageing, 8: 99-107.
    PubMed  |  

  46. Helmer, C., E.L. Peuchant, I. Bourdel-Marchasson and S. Larrieu et al., 2003. Association between antioxidant nutritinal indicators and the incidence of dementia: Results from the PAQUID prospective cohort study. Eur. J. Clin. Nutr., 57: 1555-1561.
    PubMed  |  

  47. Craft, N.E., T.B. Haitema, K.M. Garnett, K.A. Fitch and C.K. Dorey, 2004. Carotenoid, tocopherol and retinol concentrations in elderly human brain. J. Nutr. Health Ageing, 8: 156-162.
    Direct Link  |  

  48. Engelhart, M.J., M.I. Geerlings, A. Ruitenberg, J.C. van Swieten, A. Hofman, J.C. Witteman and M.M. Breteler, 2002. Dietary intake of antioxidants and risk of Alzheimer disease. J. Am. Med. Assoc., 287: 3223-3229.
    CrossRef  |  PubMed  |  Direct Link  |  

  49. Laurin, D., K.H. Masaki, D.J. Foley, L.R. White and L.J. Launer, 2004. Midlife dietary intake of antioxidants and risk of late-life incident dementia: The Honolulo-Asia ageing study. Am. J. Epidemiol., 59: 959-967.
    Direct Link  |  

  50. Morris, M.C., D.C. Evans, J.L. Bienias, C.C. Tangney and D.A. Bennett et al., 2002. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. J. Am. Med. Assco., 287: 3230-3237.
    PubMed  |  

  51. Sano, M., C. Ernesto, R.G. Thomas, M.R. Klauber and K. Schafer et al., 1997. A controlled trial of selegiline, α-tocopherol, or both as treatment for Alzheimer`s disease. The Alzheimer`s disease cooperative study. N. Engl. J. Med., 336: 1216-1222.
    PubMed  |  Direct Link  |  

  52. Harman, D., 1992. Free radical theory of ageing: History. EXS, 62: 1-10.

©  2023 Science Alert. All Rights Reserved